High-Dimensional Mass Cytometric Analysis Reveals an Increase in Effector Regulatory T Cells as a Distinguishing Feature of Colorectal Tumors
- 15 March 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 202 (6) , 1871-1884
Abstract
T cell infiltration of tumors plays an important role in determining colorectal cancer disease progression and has been incorporated into the Immunoscore prognostic tool. In this study, mass cytometry was used to demonstrate a significant increase in the frequency of both conventional CD25+FOXP3+CD127lo regulatory T cells (Tregs) as well as BLIMP-1+ Tregs in the tumor compared with nontumor bowel (NTB) of the same patients. Network cluster analyses using SCAFFoLD, VorteX, and CITRUS revealed that an increase in BLIMP-1+ Tregs was a single distinguishing feature of the tumor tissue compared with NTB. BLIMP-1+ Tregs represented the most significantly enriched T cell population in the tumor compared with NTB. The enrichment of ICOS, CD45RO, PD-1, PDL-1, LAG-3, CTLA-4, and TIM-3 on BLIMP-1+ Tregs suggests that BLIMP-1+ Tregs have a more activated phenotype than conventional Tregs and may play a role in antitumor immune responses.Keywords
This publication has 41 references indexed in Scilit:
- Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammationJournal of Clinical Investigation, 2013
- Enhancing the antitumor effects of radiotherapy with combinations of immunostimulatory antibodiesOncoImmunology, 2012
- Inflammatory and regulatory T cells contribute to a unique immune microenvironment in tumor tissue of colorectal cancer patientsInternational Journal of Cancer, 2012
- Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancerInternational Journal of Cancer, 2012
- Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cellsBlood, 2012
- The immune microenvironment as a guide for cancer therapiesOncoImmunology, 2012
- Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic ContinuumScience, 2011
- Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription FactorImmunity, 2009
- IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivoBlood, 2006
- Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.Journal of Clinical Investigation, 1996